Outcomes of Relapsed/Refractory MCL Patients Treated with Zanubrutinib Monotherapy in the Second Line and in Later Lines: A Pooled Analysis from 2 Studies
POSTER 06/2020
For more information about this resource, please submit a medical information request.
Rating
